Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Molecular portraits of human breast tumours

Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

Elston, C. W., & Ellis, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,181

Repeated observation of breast tumor subtypes in independent gene expression data sets

Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 2,024

Pathological prognostic factors in breast cancer

Elston, C. W. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,744

Predicting the clinical status of human breast cancer by using gene expression profiles

West, M., Blanchette, C., Dressman, H. K., Huang, E. S., Ishida, S., Spang, R., Zuzan, H., Olson, J. A., Marks, J. R., & Nevins, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201162998 · Cited by 1,318

The Nottingham prognostic index in primary breast cancer

Galea, M. H., Blamey, R. W., Elston, C. W., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,078

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027

Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor

Chandran, V. I., Matesic, L., Locke, J. M., Skropeta, D., Ranson, M., & Vine, K. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.021 · Cited by 27

MicroRNAs and Extracellular Vesicles as Distinctive Biomarkers of Precocious and Advanced Stages of Breast Cancer Brain Metastases Development

Figueira, I., Godinho-Pereira, J., Galego, S., Maia, J., Haskó, J., Molnár, K., Malhó, R., Costa‐Silva, B., Wilhelm, I., Krizbai, I. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105214 · Cited by 28

Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7

Gandhi, R., Khatri, N., Baradia, D., Vhora, I., & Misra, A. R. (2015) · Drug Delivery · doi:10.3109/10717544.2014.999960 · Cited by 27

Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes

Gantner, B. N., Palma, F. R., Pandkar, M. R., Sakiyama, M. J., Arango, D., DeNicola, G. M., Gomes, A. P., & Bonini, M. G. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.005 · Cited by 29

Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer

Peng, C., Chen, Y., & Jiang, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1499125 · Cited by 28

DACH1: Its Role as a Classifier of Long Term Good Prognosis in Luminal Breast Cancer

Powe, D. G., Dhondalay, G. K., Lemetre, C., Allen, T. J., Habashy, H. O., Ellis, I. O., Rees, R. C., & Ball, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084428 · Cited by 27

Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer

Joseph, C., Al-izzi, S., Alsaleem, M. A., Kurozumi, S., Toss, M. S., Arshad, M., Goh, F. Q., Alshankyty, I. M., Aleskandarany, M. A., Ali, S., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0589-0 · Cited by 25

Revealing the Dynamic Mechanism by Which Transferrin Promotes the Cellular Uptake of HAIYPRH Peptide-Conjugated Nanostructures by Force Tracing

Li, S., Wang, R., Li, J., Liu, Y., Fu, Y., Zhou, J., Yang, G., & Shan, Y. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c01119 · Cited by 25

A microfluidic approach to fabricate sucrose decorated liposomes with increased uptake in breast cancer cells

Khorshid, S., Montanari, M., Benedetti, S., Moroni, S., Aluigi, A., Canonico, B., Papa, S., Tiboni, M., & Casettari, L. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.07.015 · Cited by 25

Expanding the Utility of β-Galactosidase Complementation: Piece by Piece

Broome, A., Bhavsar, N., Ramamurthy, G., Newton, G. A., & Basilion, J. P. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900188e · Cited by 25

Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma

Vazana-Barad, L., Granot, G., Mor-Tzuntz, R., Levi, I., Dreyling, M. H., Nathan, I., & Shpilberg, O. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.734614 · Cited by 25

Identification SYT13 as a novel biomarker in lung adenocarcinoma

Zhang, L., Fan, B., Zheng, Y., Lou, Y., Cui, Y., Wang, K., Zhang, T., & Tan, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29224 · Cited by 24

Immunophenotyping invasive breast cancer: paving the road for molecular imaging

Vermeulen, J. F., van Brussel, A. S. A., van der Groep, P., Morsink, F. H. M., Bult, P., van der Wall, E., & van Diest, P. J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-240 · Cited by 23

Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia

Płoszyńska, A., Rückemann-Dziurdzińska, K., Jóźwik, A., Mikosik, A., Lisowska, K. A., Balcerska, A., & Witkowski, J. M. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0040 · Cited by 23

Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy

Abuzaid, H., Abdelrazig, S., Ferreira, L., Collins, H. M., Kim, D., Lim, K., Kam, T., Turyanska, L., & Bradshaw, T. D. (2022) · ACS Omega · doi:10.1021/acsomega.2c00997 · Cited by 22

The Impact of Iron on Cancer-Related Immune Functions in Oncology: Molecular Mechanisms and Clinical Evidence

Badran, O., Cohen, I., & Bar‐Sela, G. (2024) · Cancers · doi:10.3390/cancers16244156 · Cited by 26

Frontiers in Suicide Gene Therapy of Cancer

Malecki, M. (2012) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000e114 · Cited by 22

A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage

Ye, J., Ma, J., Liu, C., Huang, J.-X., Wang, L., & Zhong, X. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.013 · Cited by 21

Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor

Fu, M., He, Q., Guo, Z., Zhou, X., Li, H., Zhao, L., Tang, H., Zhou, X., Zhu, H., Shen, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01396 · Cited by 20

Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production

Akam, E. A., Utterback, R. D., Marcero, J. R., Dailey, H. A., & Tomat, E. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.12.016 · Cited by 20

CD71+ Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells

Leung, T. H.-Y., Tang, H. W., Siu, M. K.-Y., Chan, D. W., Chan, K. K. L., Cheung, A., & Ngan, H. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0068 · Cited by 21

Estrogen-dependent disruption of intracellular iron metabolism augments the cytotoxic effects of doxorubicin in select breast and ovarian cancer cells

Bajbouj, K., Shafarin, J., & Hamad, M. A. (2019) · Cancer Management and Research · doi:10.2147/cmar.s204852 · Cited by 20

NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1

Shan, J., Jiang, W., Chang, J., Zhou, T. Y., Chen, Y., Zhang, Y., Wang, J., Wang, Y., Wang, Y., Xu, X. L., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80737 · Cited by 19

p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles

Rejeeth, C., & Kannan, S. (2014) · Breast Cancer · doi:10.1007/s12282-014-0537-z · Cited by 19

Inhibition of NF-κB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis

Bonavida (2010) · International Journal of Oncology · doi:10.3892/ijo_00000615 · Cited by 18

Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer

Zhang, K., Li, J., Xin, X., Du, X., Zhao, D., Qin, C., Han, X., Huo, M., Yang, L., & Yin, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13121990 · Cited by 17

A liquid chromatography‐tandem mass spectrometry‐based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer

Yang, T., Xu, F., Zhao, Y., Wang, S., Yang, M., & Chen, Y. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300109 · Cited by 17

Transferrin-Conjugated pH-Responsive γ-Cyclodextrin Nanoparticles for Antitumoral Topotecan Delivery

Yoon, S., Kim, Y., Youn, Y. S., Oh, K. T., Kim, D., & Lee, E. S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111109 · Cited by 16

Clinical value of high expression level of CD71 in acute myeloid leukemia

Wu, B., SHI, N., Li, S., & LIU, L. (2016) · Neoplasma · doi:10.4149/neo_2016_519 · Cited by 16

All-in-one superparamagnetic and SERS-active niosomes for dual-targeted in vitro detection of breast cancer cells

Maurer, V., Zarinwall, A., Wang, Z., Wundrack, S., Wundrack, N., Seleci, D. A., Helm, V., Otenko, D., Frank, C., Schaper, F., et al. (2022) · Sensors & Diagnostics · doi:10.1039/d2sd00020b · Cited by 15

C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression

Wan, Y., Adair, K., Herrmann, A., Shan, X., Xia, L., Duckworth, C. A., & Yu, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06082-7 · Cited by 16

Peritubular myoid cell‐derived factors and its potential role in the progression of testicular germ cell tumours

Díez-Torre, A., Silván, U., Moreno-Ruiz, P., Gumucio, J., & Aréchaga, J. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2011.01168.x · Cited by 15

Role of Fe, Transferrin and Transferrin Receptor in Anti-Tumor Effect of Vitamin C

Qiu, J., Wu, R., Long, Y., Peng, L., Yang, T., Zhang, B., Shi, X., Liu, J., & Zhang, X. (2022) · Cancers · doi:10.3390/cancers14184507 · Cited by 14

Noninvasive longitudinal PET/CT imaging of CAR T cells using PSMA reporter gene

Song, X., Zhang, Y., Lv, X., Xu, Z., Yu, L., Gai, Y., Jiang, D., Lei, P., & Lan, X. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06508-6 · Cited by 14

Microfluidic cell surface antigen expression analysis using a single antibody type

Zhang, Y., & Pappas, D. (2016) · The Analyst · doi:10.1039/c5an02338f · Cited by 14

Synthesis and evaluation of MR probes for targeted-reporter imaging

Verma, K. D., Massing, J. O., Kamper, S. G., Carney, C. E., MacRenaris, K. W., Basilion, J. P., & Meade, T. J. (2017) · Chemical Science · doi:10.1039/c7sc02217d · Cited by 14

Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer

Shibabaw, T., Teferi, B., Molla, M. D., & Ayelign, B. (2020) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s276404 · Cited by 15

Vitamin D-Mediated Anti-cancer Activity Involves Iron Homeostatic Balance Disruption and Oxidative Stress Induction in Breast Cancer

Bajbouj, K., Sahnoon, L., Shafarin, J., Al-Ali, A., Muhammad, J. S., Karim, A., Guraya, S. Y., & Hamad, M. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.766978 · Cited by 15

Highly paralleled emulsion droplets for efficient isolation, amplification, and screening of cancer biomarker binding phages

Wang, J., Tan, Y., Ling, J., Zhang, M., Li, L., Liu, W., Huang, M., Song, J. T., Li, A., Song, Y., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc01146k · Cited by 13

Role of the human cytochrome b561 family in iron metabolism and tumors (Review)

Zhou, X., An, Z., Lei, H., Liao, H., & Guo, X. (2024) · Oncology Letters · doi:10.3892/ol.2024.14857 · Cited by 12

In silico analyses reveal new putative Breast Cancer RNA-binding proteinsPreprint

Guerrero, S. X., López‐Cortés, A., Garcí­a-Cárdenas, J. M., Armendáriz‐Castillo, I., Zambrano, A. K., Indacochea, A., Pérez‐Villa, A., Yumiceba, V., Guevara‐Ramírez, P., Jácome-Alvarado, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.08.898965 · Cited by 12

Targeting ferroptosis: a promising avenue for ovarian cancer treatment

Wu, X., Liu, Q., Jiang, Z., Wang, G., Liao, L., Ye, X.-J., Xing, M., Sun, H., Liu, Q., & Liu, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1578723 · Cited by 11

Targeting the Difficult-to-Drug CD71 and MYCN with Gambogic Acid and Vorinostat in a Class of Neuroblastomas

Bishayee, K., Habib, K., Sadra, A., & Huh, S. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000134 · Cited by 11

Synergetic collision and space separation in microfluidic chip for efficient affinity-discriminated molecular selection

Wang, J., Li, L., Zhang, Y., Zhao, K., Chen, X., Shen, H., Chen, Y., Song, J. T., Ma, Y., Yang, C. J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211538119 · Cited by 11

Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer

Zhang, S., Chen, M., Geng, Z., Liu, T., Li, S., Yu, Q., Cao, L., & Liu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317056 · Cited by 11

The Importance of Nonpharmacogenetic Factors in Endocrine Therapy

McCowan, C., & Thompson, A. M. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.29 · Cited by 11

Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population

Jiang, Y., Du, F., Chen, F., Qin, N., Jiang, Z., Zhou, J. L., Jiang, T., Pu, Z., Cheng, Y., Chen, J., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22659 · Cited by 11

The war against cancer: Suicide gene therapy

İzmirli, M., Sönmez, D., & Göğebakan, B. (2016) · Advances in Modern Oncology Research · doi:10.18282/amor.v2.i3.103 · Cited by 10

[The role of ferroptosis in chronic diseases].

Chen, J., Xiang, Y., Fang, X., Wang, F., & Min, J. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.02.24 · Cited by 11

A mitochondria targeting Mn nanoassembly of BODIPY for LDH-A, mitochondria modulated therapy and bimodal imaging of cancer

Boison, D., Lu, W., Xu, Q., Huang, Y., Huang, T., Chen, Q., Gao, J., & Zhao, Y. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.024 · Cited by 10

NGAL promotes recruitment of tumor infiltrating leukocytes

Pacifico, F., Pisa, L., Mellone, S., Cillo, M., Lepore, A., & Leonardi, A. (2018) · Oncotarget · doi:10.18632/oncotarget.25625 · Cited by 10

Cell Death and Disease

Xu, K. (2022) · Biochemistry · doi:10.5772/intechopen.104360 · Cited by 9

Expression of iron-related proteins in feline and canine mammary gland reveals unexpected accumulation of iron

Marques, O., Canadas‐Sousa, A., Faria, F., Oliveira, E., Amorim, I., Seixas, F., Gama, A., Lobo‐da‐Cunha, A., da Silva, B. M., Porto, G., et al. (2017) · Biotechnic & Histochemistry · doi:10.1080/10520295.2017.1369160 · Cited by 11

CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients

Hansen, F. J., Mittelstädt, A., Clausen, F.-N., Knoedler, S. A., Knoedler, L., Klöckner, S., Kuchenreuther, I., Mazurie, J., Arnold, L.-S., Anthuber, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70916-3 · Cited by 9

Estrogen-dependent changes in serum iron levels as a translator of the adverse effects of estrogen during infection: A conceptual framework

Hamad, M. A., & Awadallah, S. M. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.019 · Cited by 9

DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage

Greenshields, A. L., Coombs, M. R. P., Fernando, W., Holbein, B. E., & Hoskin, D. W. (2019) · BioMetals · doi:10.1007/s10534-019-00222-3 · Cited by 9

MicroRNAs and Extracellular Vesicles in Liquid Biopsies as Biomarkers of Different Stages of Breast Cancer Brain Metastases

Figueira, I., Godinho-Pereira, J., Galego, S., Maia, J., Haskó, J., Molnár, K., Malhó, R., Costa‐Silva, B., Wilhelm, I., Krizbai, I. A., et al. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamol2ed.2.2021.40 · Cited by 9

Expression of genes related to iron homeostasis in breast cancer

Mutlu, T., Özoran, E., Trabulus, D. C., Talu, C. K., Erhan, D., Mete, M., & Güven, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08433-1 · Cited by 9

Iron, Copper, and Selenium: Cancer's Thing for Redox BlingPreprint

Terzi, E. M., & Possemato, R. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041545 · Cited by 9

Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation

Zhou, X., Guo, X., Han, J., Wang, M., Liu, Z., Ren, D., Zhao, J., & Li, Z. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113760 · Cited by 8

Complex formation reactions of gallium(III) and iron(III/II) with l-proline-thiosemicarbazone hybrids: A comparative study

Bacher, F., Dömötör, O., Enyedy, É. A., Filipović, L., Radulovic, S. S., Smith, G. S., & Arion, V. B. (2016) · Inorganica Chimica Acta · doi:10.1016/j.ica.2016.06.044 · Cited by 8

Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine

Guzmán-Ortiz, A. L., Aparicio‐Ozores, G., Valle‐Rios, R., Contreras, O. M., Patiño‐López, G., & Quezada, H. (2017) · Boletín Médico del Hospital Infantil de México · doi:10.1016/j.bmhimx.2017.03.005 · Cited by 8

Low expression of transferrin receptor 2 predict poor prognosis in gastric cancer patients

Zhao, Q., Ji, J. F., Cai, Q., Wang, C., Shi, M., Zhou, C., Zhu, Z., & Zhang, J. (2020) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12278 · Cited by 8

Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein

Ye, Q., Hu, H., Wang, Z., Lu, T., Hu, Z., Zeng, X., Zhang, S., Liu, J., Lei, P., Wang, C., et al. (2012) · BMC Biotechnology · doi:10.1186/1472-6750-12-91 · Cited by 8

Estrogen-Dependent Downregulation of Hepcidin Synthesis Induces Intracellular Iron Efflux in Cancer Cells In Vitro

Shafarin, J., Bajbouj, K., El-Serafi, A. T., Sandeep, D., & Hamad, M. A. (2016) · Biology and Medicine · doi:10.4172/0974-8369.1000356 · Cited by 8

Hypoxia Modulates Cellular Endocytic Pathways and Organelles with Enhanced Cell Migration and 3D Cell Invasion**

Hema Naveena, A., & Bhatia, D. D. (2023) · ChemBioChem · doi:10.1002/cbic.202300506 · Cited by 7

Modulation of ferroptosis by non‑coding RNAs in cancers: Potential biomarkers for cancer diagnose and therapy

Gong, H., Li, Z., Wu, Z., Lian, G., & Su, Z. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155042 · Cited by 7

Targeted Delivery of BMS-1166 for Enhanced Breast Cancer Immunotherapy

Yu, Z., Zhou, Z., & Zhao, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s497089 · Cited by 7

Detection of Transferrin Receptor CD71 on a Shear Horizontal Surface Acoustic Wave Biosensor

Lo, X.-C., Lee, M., & Yao, D. (2020) · IEEE Open Journal of Nanotechnology · doi:10.1109/ojnano.2020.3044352 · Cited by 7

Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model

Conti, G., Pitea, M., Ossanna, R., Opri, R., Tisci, G., Falvo, E., Innamorati, G., Ghanem, E., Sbarbati, A., Ceci, P., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111622 · Cited by 7

Beyond Iron: The Roles of CD71 in the Pathophysiology of Cancer—A Comprehensive Review

Markopoulos, G. S., Simos, Y. V., Tsamis, K. I., Gartzonika, K., Peschos, D., & Lakkas, L. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238265 · Cited by 6

Integrated In Silico Analyses Identify PUF60 and SF3A3 as New Spliceosome-Related Breast Cancer RNA-Binding Proteins

Garcí­a-Cárdenas, J. M., Armendáriz‐Castillo, I., Pérez‐Villa, A., Indacochea, A., Jácome-Alvarado, A., López‐Cortés, A., & Guerrero, S. X. (2022) · Biology · doi:10.3390/biology11040481 · Cited by 7

Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles

Movassaghian, S., Xie, Y., Hildebrandt, C., Rosati, R., Li, Y., Kim, N. H., Conti, D. S., da Rocha, S. R. P., Yang, Z.-Q., & Merkel, O. M. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00948 · Cited by 6

Blood classical monocytes phenotype is not altered in primary non-small cell lung cancer

Almatroodi, S. A. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i5.1078 · Cited by 6

Iron metabolism in prostate cancer

Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00011-4 · Cited by 5

In vitro identification and characterisation of iron chelating catechol-containing natural products and derivatives

Hawula, Z. J., Davis, R. A., Wallace, D. F., Rishi, G., & Subramaniam, V. N. (2021) · BioMetals · doi:10.1007/s10534-021-00312-1 · Cited by 5

Magnetic and MRI Contrast Properties of HumAfFt-SPIONs: Investigating Superparamagnetic Behavior and Enhanced T2-Weighted Imaging Performance

Affatigato, L., Licciardi, M., D’Oca, M. C., Cicero, L. L., Bonamore, A., Incocciati, A., Macone, A., Buch, C. D., Piligkos, S., Boffi, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083505 · Cited by 4

Antiproliferative and cytotoxic action of N-(p-coumaroyl) serotonin in lung cancer cells.

Mitsis, M. C., Markopoulos, G. S., Alexiou, G. Α., Vartholomatos, E., Lazari, D. M., Hodaj, E., Nastos, D., Lianos, G. D., Zagorianakou, P., Galani, V., et al. (2018) · PubMed · Cited by 4

Protein-Decorated Microbubbles for Ultrasound-Mediated Cell Surface Manipulation

Brans, V. A., Gray, M. D., Sezgin, E., & Stride, E. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00861 · Cited by 4

Macroscopic fluorescence lifetime-based Förster resonance energy transfer imaging for quantitative ligand–receptor binding

Rudkouskaya, A., Faulkner, D. E., Sinsuebphon, N., Intes, X., & Barroso, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00012-0 · Cited by 4

A microfluidic technique to estimate antigen expression on particles

Ghonge, T., Ganguli, A., Valera, E., Saadah, M., Damhorst, G. L., Berger, J., Diaz, G. P., Hassan, U., Chheda, M., Haidry, Z., et al. (2017) · APL Bioengineering · doi:10.1063/1.4989380 · Cited by 4

Impact of cellular CD71 (transferrin receptor 1) expression in Egyptian acute leukemia: correlation with clinicopathologic features

El‐Menshawy, N., Abd-Aziz, S. M., Ebrahim, M. A., & Elmalky, N. (2016) · Comparative Clinical Pathology · doi:10.1007/s00580-015-2213-x · Cited by 4

PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer

Arora, G. K., Loughran, R. M., Ly, K., Galapate, C. M., Lope, A. L., Anderson, T. R., Zhang, C. Y., Grenier, S. F., Li, L., Crabtree, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116199 · Cited by 3

Proteomics-Based Disease Biomarkers

Misek, D. E., Kondo, T., & Duncan, M. W. (2011) · International Journal of Proteomics · doi:10.1155/2011/894618 · Cited by 3

Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature

Tootee, A., Nikbin, B., Ghahary, A., Nasli‐Esfahani, E., Arjmand, B., Aghayan, H. R., Qorbani, M., & Larijani, B. A. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210203212809 · Cited by 3

An ensemble of bioinformatics and machine learning approaches to identify shared breast cancer biomarkers among diverse populations

Sultan, G., & Zubair, S. (2023) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2023.107999 · Cited by 3

Raman hyperspectral imaging of transferrin-bound iron in cancer cells

Khoo, T. C., Tubbesing, K. E., Pham, L. G. C., Desta, H., Sharikova, A. V., Barroso, M., & Khmaladze, A. T. (2019) · Label-free Biomedical Imaging and Sensing (LBIS) · doi:10.1117/12.2511397 · Cited by 3

Noninvasive Imaging of Reporter Gene Expression and Distribution In Vivo

Chuang, K.-H., & Cheng, T. (2010) · Fooyin Journal of Health Sciences · doi:10.1016/s1877-8607(10)60007-0 · Cited by 3

The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study

Чулкова, С. В., Шолохова, Е. Н., Poddubnaya, I. V., Stilidi, I. S., & Tupitsyn, N. N. (2022) · Journal of Modern Oncology · doi:10.26442/18151434.2022.3.201821 · Cited by 3

Developing Ligands to Target Transition Metals in Cancer

Utterback, R. D., & Tomat, E. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2694 · Cited by 3

Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity

Trabolsi, A., Lekakis, M., Commisso, P. M., Gandhi, N. S., Elliott, A., Liu, S. V., Ma, P. C., Hoon, D. S. B., Wei, S., Antonarakis, E. S., et al. (2026) · Cancers · doi:10.3390/cancers18091402 · Cited by 2

Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine

Guzmán-Ortiz, A. L., Aparicio‐Ozores, G., Valle‐Rios, R., Contreras, O. M., Patiño‐López, G., & Quezada, H. (2017) · Boletín Médico Del Hospital Infantil de México (English Edition) · doi:10.1016/j.bmhime.2017.11.026 · Cited by 2

Cluster of Differentiation 71 (CD71)

Salajegheh, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28140-7_8 · Cited by 2

Gene Therapy for Hepatocellular Carcinoma: An Update

Kosmidis, C. S., Koimtzis, G. D., Pantos, G., Atmatzidis, S. K., Pavlidis, E. T., Kosmidou, M. S., Efthimiadis, C., Anthimidis, G., Varsamis, N., Georgakoudi, E., et al. (2019) · Journal of Biomedicine · doi:10.7150/jbm.29161 · Cited by 2

Studying therapy effects and disease outcomes in silico using artificial counterfactual tissue samples

Paulikat, M., Schürch, C. M., & Baumgartner, C. F. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110997 · Cited by 1

Horse Spleen Apoferritin‐Encapsulated Organoruthenium Complex Bearing Pyrazolyl–Pyridine Ligand for Cytotoxic and Antimicrobial Resistance Modulations

Mounica, A., Saveetha, B., kumar, A. M., & Ganeshpandian, M. (2025) · Chemistry - An Asian Journal · doi:10.1002/asia.202500781 · Cited by 1

MiR-10a-5p suppresses hepatocellular carcinoma progression and microvascular invasion by targeting TFR1-STAT3-CD24 signaling axis

Zhang, Y., Lai, D., Wang, Z., Nong, X., Chen, Y., Xu, R., Bai, T., & Zhang, W. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1694441 · Cited by 1

Ferritin hybrid nanoparticles for vaccines, drug delivery and imaging platforms

Gette, M. S., Sudarev, V. V., Tilinova, O. M., Gretskiy, R. K., Ryzhykau, Y. L., Bregestovski, P. D., Успенский, С. А., Uversky, V. N., & Vlasov, A. V. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108910 · Cited by 1

Ligand-mediated endocytosis of nanoparticles in neural stem cells: implications for cellular magnetic resonance imaging

Zhang, Y., Guo, Y., Wu, B., Zhang, H., Liu, C., Ma, J., Dai, Y., Xu, R., & Yang, Z. (2013) · Biotechnology Letters · doi:10.1007/s10529-013-1304-5 · Cited by 1

Heterogeneity of Cancers and Its Implication for Targeted Drug Delivery

Denison, T. A., & Bae, Y. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_13 · Cited by 1

Abstract P2-06-19: Transferrin Receptor (CD71) Identifies Poor Response to Tamoxifen in Oestrogen Receptor Positive Breast Cancer Patients

Nicholson, R., Habashy, H., Gee, J. M. W., Finlay, P., Farrow, L., Jasani, B., Barrett-Lee, P. J., Robertson, J. F. R., & Ellis, I. O. (2010) · Cancer Research · doi:10.1158/0008-5472.sabcs10-p2-06-19

Экспрессия рецептора трансферрина (СD71) клетками рака молочной железы

Артамонова, Е. В., Григорьевна, К. З., Летягин, В. П., Ermilova, V. D., Ognerubov, N. A., & Tupitsyn, N. N. (2003) · Medical Immunology (Russia)

Expression of transferrin receptor 1 and β1-integrins correlates with estrogen receptor status and immune infiltration in breast cancer

Чулкова, С. В., Шолохова, Е. Н., Poddubnaya, I. V., Гладилина, И. А., Егорова, А. В., & Stilidi, I. S. (2024) · Russian Journal of Archive of Pathology · doi:10.17116/patol20248604123

PP-1-11 Transferrin receptor (cd71) expression by human breast cancer cells

Артамонова, Е. В., Vasiliev, M. V., Tupitsyn, N. M., Ognerobov, N. A., & Григорьевна, К. З. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)84051-2

Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan

Hiscox, S., Baruah, B. P., Smith, C. R., Bellerby, R., Goddard, L., Jordan, N., Poghosyan, Z. P., Nicholson, R. I., Barrett-Lee, P. J., & Gee, J. M. W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-458 · Cited by 70